Here’s a look at what the Trump administration’s decision to cut overhead funding for biomedical research means for ...
University joins lawsuit to halt NIH funding cuts, which jeopardize discoveries, treatments for a range of diseases and ...
Recent actions by the FDA and NIH in response to the current political climate have left key stakeholders in clinical trials ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
A federal district judge granted a temporary restraining order Monday, blocking the Trump administration from making drastic ...
Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...
Its architect's daughter has cystic fibrosis—and benefits from a "miracle drug" backed by an agency he's attacking.
The University of Rochester will confront significant blows to groundbreaking clinical studies, UR says in a legal challenge to cuts in NIH funding.
Last week, the NIH abruptly changed its funding rules for scientific research, prompting chaos and uncertainty for scientific researchers everywhere, including in cancer research clinical trials.
The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results